HPLC to UPLC Method Migration: An Overview of Key Considerations and Available Tools
|
|
- Ezra Morrison
- 6 years ago
- Views:
Transcription
1 HPLC to UPLC Method Migration: An Overview of Key Considerations and Available Tools Dr. Michael Swartz, Ph. D. Principal Consulting Scientist Worldwide Pharmaceutical Business Operations Waters Corporation PittCon Waters Corporation
2 Evaluation Form We Appreciate Your Opinion Please Complete Evaluation Form Qualify for drawing to win a $25 AMEX gift card (drawn at end of this session must be present to win) AND Qualify to win a Gold Package registration to Inform 2007 ($1595 value; one winner per day; winner to be notified post-pittcon) Thank You! 2007 Waters Corporation 2
3 Outline UPLC Overview Principles of Method Migration Examples Software Tools Available Summary 2007 Waters Corporation 3
4 Ultra Performance LC A New Class of Separation Science Based on chromatography columns with very small particles Based on instruments designed to take advantage of the small particles Provides Improved Resolution, Speed, and Sensitivity with no Compromises Suitable for Chromatographic Applications in General Appropriate for developing new methods Appropriate for improving existing methods 2007 Waters Corporation 4
5 Smaller Particles The Enabler of Productivity Optimal velocity range 2007 Waters Corporation 5
6 HPLC vs. UPLC : Speed, Sensitivity and Resolution 0.26 Absorbance at 270 nm HPLC x 150 mm, 5 µm Rs (2,3) = Minutes Faster, More Sensitive Methods Faster, More Sensitive, Higher Resolution Methods 0.26 Absorbance at 270 nm UPLC 1 8X Speed 3.4X Sensitivity Same Resolution 2.1 x 50 mm, 1.7 µm Rs (2,3) = Absorbance at 270 nm UPLC 4.5X Speed 2X Sensitivity 1.5X Resolution x 100 mm, 1.7 µm Rs (2,3) = Minutes Minutes 2007 Waters Corporation 6
7 Method Conversion From HPLC to ACQUITY UPLC Why Convert HPLC Methods to UPLC? Get faster results with more resolution o More information o More robust methods o Better situational response time (stat samples faster, research decisions with more information, process monitoring, product release) o More samples analyzed per system, per scientist Increased Productivity 2007 Waters Corporation 7
8 Migrating Methods The New Method Must Preserve Complete resolution of all relevant analytes Peak homogeneity/purity Certainty of peak identification Quantitative accuracy and precision 2007 Waters Corporation 8
9 Method Migration Success? 2007 Waters Corporation 9
10 Method Migration Success! 2007 Waters Corporation 10
11 Caffeic Acid Derivatives in Echinacea Purpurea Original HPLC Method = 35 min XTerra MS C x 150 mm, 5 µm AU Minutes Final UPLC Method = 5 min ACQUITY UPLC TM BEH C x 50 mm, 1.7 µm au Minutes 2007 Waters Corporation 11
12 ACQUITY HPLC 8 Diuretics + impurity Rs = 1.86 Rs = x100mm 5µ C18 Vendor X HPLC Rs = 3.01 Rs = x100mm 5µ C18 ACQUITY (HPLC) Time in Minutes Waters Corporation 12
13 ACQUITY UPLC Transfer of HPLC method It is possible to transfer most HPLC methods to ACQUITY systems with attention to details Instrument design and performance differences could result in result differences Some adjustments may be required But: This is not taking advantage of UPLC!! 2007 Waters Corporation 13
14 Migrating Methods From HPLC to UPLC Method Transfer Between HPLC Systems o First step towards method conversion o HPLC to ACQUITY as HPLC Method Migration or Conversion HPLC separation to an ACQUITY UPLC separation Method Optimization Separation goals Method verification Method Development Systematic approach 2007 Waters Corporation 14
15 Keys for HPLC to UPLC Method Migration Success Proper Column Choice Chemistry Dimensions Keep in Mind Instrument Differences Gradient delay volume Detector data rates Proper Geometric Scaling Optimize for UPLC Don t Forget LC Theory 2007 Waters Corporation 15
16 Determination of Proper Column Chemistry EXPANDED VIEW Nucleosil C18 SELECTIVITY (ln [α] amitriptyline/acenaphthene) ACQUITY UPLC BEH XBridge C8 YMC-Pack Pro C18 Luna C18(2) XTerra MS C18 Prodigy C18 SunFire C 18 Hypersil HyPurity Elite C18 Hypersil Elite C18 Symmetry C18 Supelcosil LC-ABZ+Plus XTerra RP18 Chromolith TM RP-18 ACQUITY UPLC BEH XBridge Phenyl SunFire C 8 Atlantis dc 18 Supelcosil LC DB-C18 YMC-Pack ODS AQ Polaris C18-A HYDROPHOBICITY (ln [k] acenaphthene) ACQUITY UPLC BEH XBridge C18 Zorbax Rx C18 Zorbax Eclipse XDB C18 Luna C18 Inertsil ODS-3 SymmetryShield RP18 ACQUITY UPLC BEH XBridge Shield RP /2006 ph Waters Corporation 16
17 Determination of Proper Column Dimensions Internal diameter Generally prefer 2.1 mm Only use 1 mm for specific reason o Severely sample limited o Direct flow to mass spectrometer Length If primary goal is SPEED o 50 mm length to start If primary goal is RESOLUTION o 100 mm length to start 2007 Waters Corporation 17
18 Instrument Differences: Compensating for System Volumes Compare system volumes This volume should be converted to column volumes for the best comparison If target system gives smaller isocratic segment ADD an initial hold to the gradient table to give the identical hold. If target system gives larger isocratic segment No exact compensation is possible Chromatographic effect of extra isocratic hold usually small 2007 Waters Corporation 18
19 Method Migration Example Original HPLC Method Objective: Maintain resolution while increasing speed Resolution (1,2) = 12 Resolution (2,3) = 28 Absorbance 254 nm Original Column: 4.6 x 150 mm, ml/min Ambient temperature: C Flow rate: 1.50 ml/min Sample analytes: 1. Caffeine (100mg/mL), 2. Hydroquinidine (33mg/mL), 3. 3-Aminobenzophenone (39mg/mL) Molecular weight(s): Less than 500 Sample diluent: DMSO Injection: 10μL Detection: 254nm Mobile phase: A: 0.05% TFA in water B: 0.05% TFA in acetonitrile Minutes 2007 Waters Corporation 19
20 Method Migration Column Comparison: Injection Volumes HPLC 4.6 x 150mm 20μL injection/2.49ml = 0.8% UPLC 2.1 x 50mm 20μL injection/0.19ml = 11% Sample volume too large for smaller column volume 2007 Waters Corporation 20
21 Method Migration Column Comparison: Injection Volumes Column transfer from 4.6mm to 2.1mm i.d. No injection volume scaling AU Minutes 2007 Waters Corporation 21
22 Method Migration Example Injection Volume Considerations Geometrically scale injection volume to volume of column Capacity proportional to surface area and internal solvent volume Suggested minimum injection volume on the instrument is µl If calculated volume too small for injection, dilute 5-10x with initial strength mobile phase Typically 5 µl maximum injection on 2.1 x 50 mm 2007 Waters Corporation 22
23 Method Migration Calculate Injection Volume Target injection volume = Original injection volume X Target Column Volume Original Column Volume Scaling a 10µL injection on 4.6 x 150mm to 2.1 x 50mm 10μL x 3.14 x 1.12 x x x 150 = 10μL x = = 0.8μL 10μL x Waters Corporation 23
24 Method Migration Example Flow Rate For Migration: First, adjust flow rate proportional to column diameter squared for constant linear velocity (geometrically scaled) Second, adjust Gradient Table to maintain the same number of column volumes of solvent through the target column Finally, adjust flow rate (linear velocity) for smaller particle oanalyte molecular weight must be considered 2007 Waters Corporation 24
25 Method Migration Scale the Flow Rate to Column Geometry Scaling a 1.5mL/min flow rate on 4.6x150mm to 2.1x50mm* Target Flow Rate = Original Flow Rate x π x r 2 of Target π x r 2 of Original This reduces to: Target Flow Rate = Original Flow Rate x So: d 2 Target d 2 Original 1.5mL/min. X = 0.31mL/min. *Note: this assumes same particle size 2007 Waters Corporation 25
26 Method Migration Example Gradient Profile Express gradient duration in percent change per column volume (cv) units Calculate each segment as a number of column volumes Calculate time required to deliver the same number of column volumes to the target column at the chosen flow rate 2007 Waters Corporation 26
27 Original Gradient Profile Gradient Step Time Since Injection Flow Rate %A %B Curve Initial * Waters Corporation 27
28 Gradient Segments Express as Column Volumes For 15 min at 1.5mL/min on a 4.6 x 150mm column Gradient Volume = Flow Rate x Time = 1.5mL/min x 15min = 22.5mL Column Volume = π x r 2 x L = 3.14 x x 15.0 = 2.49mL Gradient Duration (cv) = Gradient Volume Column Volume Gradient Duration = 22.5mL 2.49mL = 9.03 cv 2007 Waters Corporation 28
29 Original Gradient Profile for Scaling Step Time Since Injection Flow Rate %A % B Curve Segment Duration (min) Segment Duration (cv) Initial * Waters Corporation 29
30 Scaling Gradient Step Time Maintain Duration (cv( cv) Original Step 2: ml/min with duration of 9.03cv Calculate Target Step 2: (keeping 9.03cv) Column Volume = π x r2 x L = 3.14 x x 5.0 = 0.17mL Gradient Step Volume = Duration (cv) x Target Column Volume = 9.03cv x 0.17mL = 1.54mL Gradient Step Time = Gradient Step Volume/Flow Rate = 1.54mL / 0.31 ml/min = 5 min 2007 Waters Corporation 30
31 Scaled Gradient Profile 2.1x50mm Column Adjust time for same number of column volumes per gradient segment Gradient Step Time Since Injection Flow Rate % A % B Curve Segment Duration (min) Segment Duration (cv) Initial * Waters Corporation 31
32 Smaller Particles The Enabler of Productivity Optimal velocity range 2007 Waters Corporation 32
33 Estimate Optimum Flow Rate UPLC Consider 1.7µm target particle (2.1mm ID column) Assume temperature and viscosity transferred Adjust flow rate based on van Deemter curve and approximate molecular weight ~0.6 ml/min for smaller molecules o average 500 dalton (molecular weight) molecules ~0.1 ml/min for larger molecules because diffusion is slower o e.g., ~2,000 dalton peptides 2007 Waters Corporation 33
34 Scaling for UPLC Flow Rate Step Time to Maintain Duration (cv( cv) Original Step 2: ml/min with Duration of 9.03cv Calculate Target Step 2: (keeping 9.03cv) Target Column Volume (2.1 x 50) = 0.17mL Gradient Step Volume = Duration (cv) x Target Column Volume = 9.03cv x 0.17mL = 1.54mL Gradient Step Time = Gradient Step Volume / UPLC Flow Rate = 1.54mL / 0.60 ml/min. = 2.6min 2007 Waters Corporation 34
35 Optimized Gradient Profile Select UPLC flow rate and adjust time to maintain same number of column volumes per segment Gradient Step Time Since Injection Flow Rate % A % B Curve Segment Duration (min) Segment Duration (cv) Initial * Waters Corporation 35
36 Method Conversion Process: Steps for Success Review steps Refer to current chromatography Observe system volumes, solvents and detection technique Define objectives/room for improvement Select column dimensions scale flow for linear velocity 50 mm length for speed 100mm length for complex samples/resolution Scale injection volume to column dimensions Use a gradient and flow scaled from current method Adjust gradient to accommodate system differences, column differences and particle size differences Use a gradient and flow rate scaled for UPLC 2007 Waters Corporation 36
37 Method Conversion: Original HPLC Method Resolution (1,2) = 12 Resolution (2,3) = 28 Absorbance 254 nm Original Column: 4.6 x 150 mm, ml/min, 30 minute cycle time Ambient temperature: C Flow rate: 1.50 ml/min Sample analytes: 1. Caffeine (100mg/mL), 2. Hydroquinidine (33mg/mL), 3. 3-Aminobenzophenone (39mg/mL) Molecular weight(s): Less than 500 Sample diluent: DMSO Injection: 10μL Detection: 254nm Mobile phase: A: Water B: acetonitrile C: 1.0% TFA in water Gradient: (A/B/C) 90/5/5 to 0/95/5 in 15 minutes (Curve 6) hold for 5 minutes then to initial conditions (curve 11) hold for 10 minutes Minutes 2007 Waters Corporation 37
38 Method Conversion Scaled UPLC Resolution 1,2 = 11 Resolution 2,3 = 26 Absorbance 254 nm ACQUITY UPLC BEH C18, 1.7 µm, 2.1 x mL/min Column Temp: 30ºC Sample analytes: 1. Caffeine (100mg/mL), 2. Hydroquinidine (33mg/mL), 3. 3-Aminobenzophenone (39mg/mL) Molecular weight(s): Less than 500 Sample diluent: DMSO Injection: 0.8μL Detection: 254nm Mobile phase: A: 0.05% TFA in water B: 0.05% TFA in acetonitrile Gradient: (A/B) 95/5 to 5/95 in 2.61 minutes (Curve 6) hold for 0.87 minutes then to initial conditions (curve 11) hold for 1.74 minutes Minutes 2007 Waters Corporation 38
39 Method Conversion Scaled UPLC Magnified Absorbance 254 nm Resolution 1,2 = 11 Resolution 2,3 = UPLC : 2.1 x 50 mm column, 0.6mL/min, 5.2 minute cycle time Minutes 2007 Waters Corporation 39
40 Original HPLC Method Critical resolution Absorbance 254 nm Resolution 1,2=12 Resolution 2,3= Baseline and presence of unknown peaks Minutes 2007 Waters Corporation 40
41 Absorbance 254 nm UPLC Magnified View Critical resolution Resolution 1,2=11 Resolution 2,3= Same resolving power and sensitivity Minutes 2007 Waters Corporation 41
42 ACQUITY UPLC Calculator 2007 Waters Corporation 42
43 Method Conversion Significantly Different Column Chemistry At what point does method conversion become method development? When column chemistries are different, try a modified method development approach Proposed Strategy 1: Understand general column selectivity differences Follow chemistry and system scaling protocols Generic gradients : 10 to 90 % organic solvent Run a short gradient (3 min) and a long gradient (6 min) Optimization tools (simulation software) are useful Proposed Strategy 2: Follow method development protocols 2007 Waters Corporation 43
44 Automated Method Development Automated Method Development ACQUITY UPLC Column Manager, 4 column selection device ACQUITY UPLC Binary Solvent Manager, solvent select valves 2007 Waters Corporation 44
45 UPLC Systematic Screening Four ACQUITY UPLC Chemistries 2.1 x 50 mm, 1.7 µm: ACQUITY UPLC TM BEH C 18 ACQUITY UPLC TM BEH Shield RP 18 ACQUITY UPLC TM BEH C 8 ACQUITY UPLC TM BEH Phenyl Solvents: Acetonitrile Methanol Buffers: ph 3 ammonium formate ph 10 ammonium bicarbonate 2007 Waters Corporation 45
46 Experimental Matrix ph 3, Acetonitrile ph 3, Methanol ph 10, Acetonitrile ph 10, Methanol C18 Shield RP18 C8 Phenyl 2007 Waters Corporation 46
47 Automated Column and Solvent Scouting 2007 Waters Corporation 47
48 Total Time and Solvents Calculated 2007 Waters Corporation 48
49 Can I transfer the method to other systems that have a standard column heater? AU ACQUITY UPLC with PDA & Column Manager AU ACQUITY UPLC with TUV & standard Column Heater Minutes 2007 Waters Corporation 49
50 Develop Methods Faster with UPLC : Time Savings UPLC Methods Development Protocol 2.1 x 50 mm, 1.7 µm ph 3/ acetonitrile Time Flow ramp 5 min Column conditioning (2 blank gradients) 11 min Sample injection (2 replicates) 11 min ph 3/ methanol Flow ramp 5 min Column conditioning (2 blank gradients) 11 min Sample injection (2 replicates) 11 min Column purge 6 min ph 10/ acetonitrile Flow ramp 5 min Column conditioning (2 blank gradients) 11 min Sample injection (2 replicates) 12 min ph 10/ methanol Flow ramp 5 min Column conditioning (2 blank gradients) 11 min Sample injection (2 replicates) 11 min Column purge 6 min 120 min EQUIVALENT HPLC Methods Development Protocol 4.6 x 150 mm, 5 µm ph 3/ acetonitrile Time Flow ramp 5 min Column conditioning (2 blank gradients) 80 min Sample injection (2 replicates) 80 min ph 3/ methanol Flow ramp 5 min Column conditioning (2 blank gradients) 80 min Sample injection (2 replicates) 80 min Column purge 35 min ph 10/ acetonitrile Flow ramp 5 min Column conditioning (2 blank gradients) 80 min Sample injection (2 replicates) 80 min ph 10/ methanol Flow ramp 5 min Column conditioning (2 blank gradients) 80 min Sample injection (2 replicates) 80 min Column purge 35 min 730 min SCREENING TIME 2 Hours/column x 4 columns SCREENING TIME 12.2 Hours/column x 4 columns TOTAL SCREENING TIME 8 HOURS TOTAL SCREENING TIME 48.8 HOURS 2007 Waters Corporation 50
51 Conclusion Strategies and Tools For HPLC to UPLC Method Migration Column chemistry and dimensions Instrument considerations Proper scaling Optimization Redevelopment Method migration/conversion calculator 2007 Waters Corporation 51
52 Acknowledgements Diane Diehl Eric Grumbach Jeff Mazzeo Uwe Neue Michael Jones Andy Aubin Craig Dobbs And: 2007 Waters Corporation 52
53 Inform 2007 Waters premier Laboratory Informatics symposium where users can network with colleagues, share experiences, and gain valuable insights into how to best deploy and use Waters Informatics suite of solutions May 7-10, 2007 Miami Marriott Biscayne Bay Three-day event with optional tutorials Monday: (2) ½ Day Tutorial Session Tuesday Thursday: Symposium Download the agenda and register at: Waters booth Fill out a seminar evaluation form and enter the raffle to win a Gold Package registration* for Inform 2007 which includes all tutorials and workshops - a $1595 value One drawing daily. Winner will be notified. * Prize covers conference registration only 2007 Waters Corporation 54
HPLC to UPLC: Method Transfer and Development
Method Transfer From HPLC to UPLC Methods Transfer Considerations Four classes of generic HPLC methods transfer include: Replace a longer column with a shorter column Replace a column brand with another
More informationSimple Techniques for Improving the Isolation of Synthetic Peptides Jo-Ann Jablonski Principal Scientist Waters Corporation
Simple Techniques for Improving the Isolation of Synthetic Peptides Jo-Ann Jablonski Principal Scientist Waters Corporation 2016 Waters Corporation 1 Agenda Background Techniques Scaling a separation Focusing
More informationUpdate to USP <621> Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014
Update to USP Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014 2015 Waters Corporation 1 What is the USP-NF? The United States Pharmacopeia National Formulary (USP-NF)
More informationDeveloping Quantitative UPLC Assays with UV
Developing Quantitative UPLC Assays with UV Detection for Antibodies & Other Proteins Steve Taylor 2011 Waters Corporation 1 Outline UPLC technology for RP protein separations Method development parameters
More informationACQUITY Arc TM System
ACQUITY Arc TM System Introducing the Newest Member of the Waters LC Portfolio 2015 Waters Corporation 1 Adopting Modern LC Technology in a Global Economy Highly competitive, regulated business environment
More informationAnalytical Instrument Qualification According to USP <1058>: Requirements and Examples for the Agilent 1290 Infinity LC System
Analytical Instrument Qualification According to USP : Requirements and Examples for the Agilent 1290 Infinity LC System 1) USP : Scope, approach, requirements 2) Qualification Examples for
More informationQuality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC
Quality-by-Design-Based Method Development Using an Agilent 129 Infinity II LC An Efficient Method Development Workflow Combined with ISET-mediated Method Transfer Under Waters Empower 3 CDS Control Application
More informationMethod Development Considerations for Reversed-Phase Protein Separations
Method Development Considerations for Reversed-Phase Protein Separations Hillary B. Hewitson, Thomas E. Wheat, Paula Hong, Kenneth J. Fountain APPLICATION BENEFITS n The BEH00 C 4 chemistry is available
More informationFUTURE-PROOF SOLUTIONS FOR REGULATED LABORATORIES IN THE FACE OF CHANGING USP <621> GUIDELINES
FUTURE-PROOF SOLUTIONS FOR REGULATED LABORATORIES IN THE FACE OF CHANGING USP GUIDELINES How to use UPLC technology within allowable adjustments to improve QC laboratory throughput For many in the
More informationUsing High Temperature HPLC for Improved Analysis in the Pharmaceutical Industry
Using High Temperature HPLC for Improved Analysis in the Pharmaceutical Industry Stephanie J. Marin Brian Jones, Dale Felix, Jody Clark Selerity Technologies, Inc. Salt Lake City, UT www.selerity.com Abstract
More informationAgilent Prep LC Columns for Small Molecules and Biomolecules MAINTAIN RAPID, RELIABLE SEPARATIONS AS YOU SCALE-UP
Agilent Prep LC Columns for Small Molecules and Biomolecules MAINTAIN RAPID, RELIABLE SEPARATIONS AS YOU SCALE-UP AGILENT PREP COLUMNS FOR HPLC FLEXIBLE, COST-EFFECTIVE OPTIONS FOR SCALING AND PREPARATIVE
More informationAutomated Scouting of Stationary and Mobile Phases Using the Agilent 1290 Infinity II Method Development Solution
Automated Scouting of Stationary and Mobile Phases Using the Agilent 129 Infinity II Method Development Solution Technical Overview Authors Edgar Naegele and Sonja Schneider Agilent Technologies, Inc.
More informationTechniques for Improving the Efficiency of Large Volume Loading in Preparative Liquid Chromatography
Techniques for Improving the Efficiency of Large Volume Loading in Preparative Liquid Chromatography Jo-Ann M. Jablonski, Andrew J. Aubin, and Wendy Harrop Waters Corporation, Milford, MA, USA APPLICATION
More informationACQUITY Arc VERSATILITY WITHOUT COMPROMISE
ACQUITY Arc VERSATILITY WITHOUT COMPROMISE BUILT UPON A FOUNDATION OF RELIABILITY With the ACQUITY Arc System, analytical scientists can experience true plug-and-play method compatibility for HPLC and
More informationAPPLICATIONS TN Overview of Kinetex 2.6 µm Core-Shell Technology
TN-7 Determination of Impurities and Related Substances for Glibenclamide (EP Monograph 78). Increased Sensitivity, Improved Resolution and Faster Analysis Using Kinetex.6 µm Core-Shell LC Columns Elli
More informationComparison Guide. Comparison Data on Commonly Used C18 Phases TO C18 REVERSED P HASE HPLC COLUMNS. Stationary Phase Specifications
Comparison Guide TO C8 REVERSED P HASE HPLC COLUMNS Comparison Data on Commonly Used C8 Phases Stationary Phase Specifications Phases Compared According to Relative Hydrophobicity Comparison of Column
More informationApplication Note. Author. Abstract. Pharmaceuticals. Detlef Wilhelm ANATOX GmbH & Co. KG. Fuerstenwalde, Germany mau
Development, validation, and comparison of an HPLC method to analyze paracetamol and related impurities according to the European Pharmacopoeia (EP) and USP using the Agilent 1120 Compact LC and the Agilent
More informationAutomated Method Development With UPLC and Fusion Software A Quality by Design-based Tool Jean-Michel Plankeele May Waters Corporation 1
Automated Method Development With UPLC and Fusion Software A Quality by Design-based Tool Jean-Michel Plankeele May 2012 2012 Waters Corporation 1 Agenda LC method development and Quality-by-Design guidelines
More informationAPPLICATIONS TN Overview of Kinetex 2.6 µm Core-Shell Technology
Determination of Impurities and Related Substances for (Ph. Eur. Monograph 8): Increased Sensitivity, Improved Resolution and Faster Analysis Using Kinetex.6 µm Core-Shell LC Columns Ellie Abbasi, Jeff
More informationInertsil ODS-3 2 µm. Base Silica Physical Properties and Chemical Modification. Base Silica: High Purity Silica Gel % Surface Area: 450 m 2 /g
0 High-Speed Separation Inertsil ODS-3 2 µm Base Silica Physical Properties and Chemical Modification Base Silica: High Purity Silica Gel 99.999% Surface Area: 450 m 2 /g Pore Size: 100 Å Pore Volume:
More informationSean M. McCarthy and Martin Gilar Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL RESULTS AND DISCUSSION
UPLC Separation of DNA Duplexes Sean M. McCarthy and Martin Gilar Waters Corporation, Milford, MA, U.S. INTRODUCTION Over the past 2 years there has been a considerable amount of effort focused on the
More informationMethod Translation in Liquid Chromatography
Method Translation in Liquid Chromatography Technical Overview Abstract Ronald E. Majors Agilent Technologies, Inc. 2850 Centerville Rd Wilmington, DE 19808 USA With the recent emphasis on high performance
More informationImproving Resolution and Column Loading Systematically in Preparative Liquid Chromatography for Isolating a Minor Component from Peppermint Extract
Improving Resolution and Column Loading Systematically in Preparative Liquid Chromatography for Isolating a Minor Component from Peppermint Extract Jo-Ann M. Jablonski and Rui Chen Waters Corporation,
More informationCustomized systems to meet your lab s needs
WATERS PURIFICATION SYSTEMS Compound purification and isolation can be more efficient and more productive With Waters systems, purify using multiple detection choices: n Ultraviolet/Visible (UV/Vis) Absorbance
More informationPart III Improving Throughput Through the Use of Elevated Column Temperature
Part III Improving Throughput Through the Use of Elevated Column Temperature Review potential approaches to improving the speed of HPLC Review the concepts of Ultra-Fast High Temperature Liquid Chromatography
More informationApplication Note. Authors. Abstract. Introduction. Pharmaceutical
Scalability of Agilent s Across HPLC and UHPLC Instruments Application Note Pharmaceutical Authors Anne E. Mack, William J. Long Agilent Technologies, Inc. 2850 Centerville Road, Wilmington, DE 19808 USA
More informationA Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate in Bulk and Dosage Forms Using RP-HPLC
Human Journals Research Article February 2018 Vol.:11, Issue:3 All rights are reserved by Priyanka Teepoju et al. A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate
More informationReplacing Solvent Gradient HPLC Methods with Temperature Programmed HTLC
Replacing Solvent Gradient HPLC Methods with Temperature Programmed HTLC Stephanie J. Marin Brian Jones, Dale Felix, Jody Clark Selerity Technologies, Inc. Salt Lake City, UT www.selerity.com Introduction
More informationPerformance characteristics of the 1260 Infinity Quaternary LC system
Performance characteristics of the 1260 Infinity Quaternary LC system The new standard in HPLC Technical Overview Introduction The Agilent 1260 Infinity LC system consists of modular units that operate
More informationPerformance Characteristics of the Agilent 1220 Infinity Gradient LC system
Performance Characteristics of the Agilent 122 Infinity Gradient LC system An integrated LC system for conventional LC and UHPLC Technical Overview 7 5 4 3 2 1.5 1 1.5 2 2.5 3 Introduction The Agilent
More informationTechnical Overview. Author. Abstract. A.G.Huesgen Agilent Technologies, Inc. Waldbronn, Germany
Transferring methods to the Agilent 129 Infinity LC System using Intelligent System Emulation Technology (ISET) Analysis of paracetamol and its impurities Technical Overview Author A.G.Huesgen Agilent
More informationAccucore. Ultimate Core Performance LC Column Technology to Maximize Your Investment. Dave Jarzinski. October 2011
Accucore Ultimate Core Performance LC Column Technology to Maximize Your Investment Dave Jarzinski Thermo Fisher Scientific Account Manager Greater Boston/Cambridge & North Phone: 978-408-1576 Email: dave.jarzinski@thermofisher.com
More informationSFC Säulen für analytische und preparative Anwendungen
SFC Säulen für analytische und preparative Anwendungen Technology Symposium Vienna, 25 th October 2016 DI Verena Schmid 2016 Waters Corporation 1 CHIRAL SEPARATIONS ACQUITY UPC 2 Trefoil 2016 Waters Corporation
More informationReversed-phase Separation of Intact Monoclonal Antibodies Using Agilent ZORBAX Rapid Resolution High Definition 300SB-C8 1.
Reversed-phase Separation of Intact Monoclonal Antibodies Using Agilent ZORBAX Rapid Resolution High Definition 3SB-C8 1.8 µm Column Application Note Biopharmaceuticals Authors James Martosella and Phu
More informationTechnical Overview. Author. Abstract. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany
New Features of the Agilent Method Scouting Wizard for Automated Method Development of Complex Samples Analysis of Large Data Sets by Method Scouting Reports and Automated Adjustment of Flow Rates and
More informationDeveloping an Analytical Impurity Control Strategy Using QbD. Mark D. Argentine
Developing an Analytical Impurity Control Strategy Using QbD Mark D. Argentine Quality by Design in Development Relies upon developing knowledge around processes and products Ref: M. Nasr, 2006 for effective
More informationUsing High Temperature HPLC for Improved Analysis in the Pharmaceutical Industry
Using High Temperature HPLC for Improved Analysis in the Pharmaceutical Industry Stephanie J. Marin Brian Jones, Dale Felix, Jody Clark Selerity Technologies, Inc. Salt Lake City, UT www.selerity.com The
More informationGenerating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI
with the Biopharmaceutical Platform Solution with UNIFI Vera B. Ivleva, Ying Qing Yu, Scott Berger, and Weibin Chen Waters Corporation, Milford, MA, USA A P P L I C AT ION B E N E F I T S The ability to
More informationA Brief Overview of HPLC & UHPLC Method Development and Optimization. Dr. Chris Message UHPLC/HPLC Product Specialist Phenomenex
A Brief Overview of HPLC & UHPLC Method Development and Optimization Dr. Chris Message UHPLC/HPLC Product Specialist Phenomenex Poll Question 1 What learning objectives most attracted you to this webinar?
More informationOriginal Paper. The role of UHPLC in pharmaceutical development. i 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 1 Introduction
J. Sep. Sci. 2007, 30 S. M. Chesnut et al. Stephen M. Chesnut John J. Salisbury Analytical Research and Development, Pfizer Global Research and Development, Groton/New London Laboratories, Groton, CT,
More informationIntroducition of a new product from Inertsil Series
Introducition of a new product from Inertsil Series is a C8 column developed focusing on superb inertness to basic, acidic, neutral and chelating compounds, which can virtually provide perfect peak shapes
More informationMaximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns
Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns Hongwei Xie, Martin Gilar, and Jeff Mazzeo Waters Corporation, Milford, MA U.S. APPLICATION BENEFITS The ACQUITY UPLC
More informationDiscovery BIO Wide Pore
Discovery BIO Wide Pore Solutions to Protein and Peptide Separation Challenges T403118 2 Agenda: What is Discovery BIO Wide Pore Physical characteristics Why we developed it and for whom Performance demonstrations
More information10. Validated Normal Phase HPLC Method for the Determination. Fulvestrant is primarily used in the treatment of hormone receptor
229 10. Validated Normal Phase HPLC Method for the Determination of Fulvestrant in Pharmaceutical Dosage Forms 10.1 Introduction Fulvestrant is primarily used in the treatment of hormone receptor positive
More informationDeveloping Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus
Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus Robert Birdsall, Thomas Wheat, and Weibin Chen Waters Corporation,
More informationPractical Applications of Method Translation Using the Agilent Method Translation Tool. eseminar and Workshop
Practical Applications of Method Translation Using the Agilent Method Translation Tool eseminar and Workshop Thomas J. Waeghe, Ph.D. Inside Application Engineer Agilent Technologies Life Sciences and Chemical
More informationEncompassing Method Development, Small Scale Purification, and Post-Purification Analysis with the Investigator SFC System
Encompassing Method Development, Small Scale Purification, and Post-Purification Analysis with the Investigator SFC System Jacquelyn Runco and Rui Chen, Ph.D. Waters Corporation, Milford, MA, USA A P P
More informationACQUITY UPLC. I-Class PLUS WHAT SEPARATES YOU FROM EVERYONE ELSE
ACQUITY UPLC I-Class PLUS WHAT SEPARATES YOU FROM EVERYONE ELSE COMPLEX CHALLENGES SOLVED Looking for answers to the most complex scientific challenges is what you do. Your research could lead to ground-breaking
More informationCase Study on Application of Analytical Life Cycle Management and Risk Management
Case Study on Application of Analytical Life Cycle Management and Risk Management Jianmei, Ph.D. Genzyme, a Sanofi Company AAPS 2015 Dione Pompe disease Brazil www.genzyme.com Outline Introduction of Concepts
More informationCertified Reference Material - Certificate of Analysis
Certified Reference Material - Certificate of Analysis T-32 Page 1 of 7 (-)- 8 -THC, Primary Standard Catalog Number: T-32 Lot: Expiration: Description: October 22 (-)- 8 -THC in Methanol. Packaging: Solution
More informationCHAPTER-3. Zolmitriptan
45 CHAPTER-3 Zolmitriptan 46 CHAPTER-3 Chapter-3 : Zolmitriptan S. No. Name of the Sub- Title Page No. 3.1 Introduction 47-49 3.2 Experimental 49-59 3.3 Method validation 59-62 3.4 Result& Discussion 62-78
More informationFaster Separations Using Agilent Weak Cation Exchange Columns
Faster Separations Using Agilent Weak Cation Exchange Columns Application Note BioPharma Author Andrew Coffey Agilent Technologies, Inc. Abstract Ion exchange is a commonly used technique for the separation
More informationA Modular Preparative HPLC System for the Isolation of Puerarin from Kudzu Root Extracts
A Modular Preparative HPLC System for the Isolation of Puerarin from Kudzu Root Extracts Andrew Aubin and Ronan Cleary Waters Corporation, Milford, MA, USA APPLICATIN BENEFITS A modular preparative HPLC
More informationBivalirudin Purification:
Bivalirudin Purification: Sorbent Screening and Overload Experiments Marc Jacob, Joshua Heng, and Tivadar Farkas Phenomenex, Inc., 411 Madrid Ave., Torrance, CA 90501 USA PO94190412_W Abstract In this
More informationA Comparison of Compendia Normal Phase LC Methods Run Under Supercritical Fluid Chromatography Conditions
A Comparison of Compendia Normal Phase LC Methods Run Under Supercritical Fluid Chromatography Conditions Stéphane Dubant Waters ESAC April 5th 2011 2011 Waters Corporation 1 Agenda Introduction and Benefits
More informationCombining High Temperature and Small Particles: The Advantages of Zirconia
Combining High Temperature and Small Particles: The Advantages of Zirconia EAS 9 Dan owlan 1, Bingwen Yan 1, Clayton V. Mceff 1, R.A. Henry 1 ZirChrom Separations, Inc. 617 Pierce St., Anoka, M 5533 Independent
More informationTHESIS SUBMITTED TO THE ANDHRA UNIVERSITY IN PARTIAL FULFILMENT FOR THE AWARD OF THE DEGREE OF DOCTOR OF PHILOSOPHY IN PHARMACEUTICAL SCIENCES
Synopsis of the Thesis entitled QUANTITATIVE DETERMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS, RELATED SUBSTANCES AND ORGANIC & POLYMORPHIC IMPURITIES IN PHARMACEUTICAL FORMULATIONS BY LIQUID CHROMATOGRAPHY
More informationAdvancedTools in HPLC methoddevelopment
AdvancedTools in HPLC methoddevelopment Remco Stol, Enrico Martina and Jeffrey Vos Analytical Sciences Chemistry, Quality Unit API/BT NL FHI symposium, Houten, 22 april 2010 What does the customer want?
More informationand for the Development of Isolation Strategies
PLC for the nalysis of Synthetic Peptides and for the Development of Isolation Strategies Joomi hn, Ziling Lu, Thomas E. Wheat, and Jeffrey R. Mazzeo Waters Corporation, Milford, M,.S. Introduction Peptides
More informationSimplifying Methods Transfer: Novel Tools for Replicating Your Established Methods on an ACQUITY Arc System
Simplifying Methods Transfer: Novel Tools for Replicating Your Established Methods on an ACQUITY Arc System Paula Hong, Richard Andrews, Peyton C. Beals, and Patricia R. McConville Waters Corporation,
More informationScale-up with the Agilent SD-1 Purification System analytical and preparative runs on a single system
Scale-up with the Agilent SD-1 Purification System analytical and preparative runs on a single system Technical Overview Author Absorbance Monitored wavelength: 230 nm Methylparaben Ethylparaben 9.717
More informationGenotoxicity is the property of a compound
Impurities Analysis in Pharmaceuticals: Genotoxicity is the property of a compound known to have irreversible effects on the structure and functionality of the DNA in cells and cause DNA loss, DNA replication
More informationADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS
Agilent AdvanceBio Columns ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS with Agilent ZORBAX RRHD 3Å 1.8 µm columns ns Rapid resolution high definition columns for UHPLC protein and peptide separations
More informationApplication Note. Biopharma. Authors. Abstract. James Martosella, Phu Duong Agilent Technologies, Inc Centreville Rd Wilmington, DE 19808
Reversed-Phase Optimization for Ultra Fast Profiling of Intact and Reduced Monoclonal Antibodies using Agilent ZORBAX Rapid Resolution High Definition 3SB-C3 Column Application Note Biopharma Authors James
More informationPeptide Mapping: A Quality by Design (QbD) Approach
Peptide Mapping: A Quality by Design (QbD) Approach Application Note Bio-Pharmaceutical Authors Sreelakshmy Menon and Suresh babu C.V. Agilent Technologies, Inc. Richard Verseput S-Matrix Corporation Abstract
More informationNatural Product Analysis Using Temperature Programmed HPLC: Sub-Ambient through 200 ºC
Natural Product Analysis Using Temperature Programmed HPLC: Sub-Ambient through 200 ºC Dale Felix, Stephanie J. Marin Brian Jones, Jody Clark Selerity Technologies, Inc. Salt Lake City, UT www.selerity.com
More information2012 Waters Corporation 1
UPLC User meeeting April 2012 Principles and Practices for SEC, IEX for Intact Protein Analysis by UPLC anders_feldthus@waters.com 2012 Waters Corporation 1 Agenda Ion-Exchange Chromatography Theory and
More informationOptimizing Purified Sample Recovery on Reverse-Phase HPLC Systems
Optimizing Purified Sample Recovery on Reverse-Phase HPLC Systems Application Note 209 Joan Stevens, PhD, Alan Hamstra, Luke Roenneburg, Tim Hegeman (Gilson, Inc.) Craig Esser, PhD, Regina Black, Derek
More informationA Guide To Speeding Up Your Separation
A Guide To Speeding Up Your Separation Page 1 Choosing The Column Overview Reducing The Column Length Changing The Column Id Adjusting The Injection Volume Transferring to 1.8um Columns Speeding It Up
More informationUltra High Performance Liquid Chromatograph. Nexera XR C196-E082D
Ultra High Performance Liquid Chromatograph Nexera XR C196-E82D The Most Accessible UHPLC Available Developed with expandability and compatibility in mind, the Nexera XR ultra high performance liquid chromatograph
More informationAutomatic Combination of Orthogonal Separation Modes for Multiple Components in Mixtures
Automatic Combination of Orthogonal Separation Modes for Multiple Components in Mixtures Thomas E. Wheat, Amanda B. Dlugasch, and Patricia R. McConville Waters Corporation IFPAC January 26, 2016 2016 Waters
More informationITSP Extraction of Cortisol from Plasma
ITSP Extraction of Cortisol from Plasma Introduction Solid Phase Extraction (SPE) is well established as a preferred tool for extracting small organic molecules from complex biological matrices (e.g. plasma)
More informationHPLC Peak Focusing Facilitated by Independent Mobile Phase Pre-heating
HPLC Peak Focusing Facilitated by Independent Mobile Phase Pre-heating Brian Jones, Stephanie J. Marin, Jody Clark, Dale Felix Selerity Technologies, Inc. 2484 W. Custer Road Salt Lake City, UT 84104 www.selerity.com
More informationEnhancing your HPLC Separations using Temperature Programming
Enhancing your HPLC Separations using Temperature Programming Brian Jones, Stephanie J. Marin, Jody Clark, and Dale Felix Selerity Technologies, Inc. 2484 W. Custer Road Salt Lake City, UT 84104 www.selerity.com
More information[ ACQUITY UPLC system ] Performance so strong it moved the industry forward
[ ACQUITY UPLC system ] ULTRA PERFORMANCE Performance so strong it moved the industry forward And brought the impact of science beyond the bench The proven performance of the ACQUITY UPLC System, used
More information[ ACQUITY UPLC SYSTEM ] Performance so strong it moved the industry forward
ULTRA PERFORMANCE Performance so strong it moved the industry forward And brought the impact of science beyond the bench The proven performance of the ACQUITY UPLC System, used in thousands of laboratories
More informationAnalysis of biomolecules by SEC and Ion-Exchange UPLC
Analysis of biomolecules by SEC and Ion-Exchange UPLC Anders Feldthus, Waters Nordic 2011 Waters Corporation 1 Waters Commitment To develop, commercialize and market columns that when used on Waters ACQUITY
More informationQuantification of genotoxic "Impurity D" in Atenolol by LC/ESI/MS/MS with Agilent 1200 Series RRLC and 6410B Triple Quadrupole LC/MS
Quantification of genotoxic "Impurity D" in Atenolol by LC/ESI/MS/MS with Agilent 12 Series RRLC and 641B Triple Quadrupole LC/MS Application Note Manufacturing Process Development Author Siji Joseph Agilent
More informationCHAPTERS 1, 2 and 3 CHAPTER-4 CHAPTER-5,
319 Presently in the pharmaceutical industry, drug analysis plays a vital role in deciding the quality and potency of the drug. The selection of analytical method used to quantify the drugs and impurities
More informationCertified Reference Material - Certificate of Analysis
Certified Reference Material - Certificate of Analysis S(+)-Methamphetamine, Primary Standard M-020 Page 1 of 7 Catalog Number: M-020 Lot: Expiration: Description: Packaging: Storage: Shipping: Intended
More information4/4/2013. BioHPLC columns. Paul Dinsmoor Biocolumn Technical Specialist. April 23-25, Size Exclusion BioHPLC Columns
BioHPLC columns Paul Dinsmoor Biocolumn Technical Specialist April 23-25, 2013 Size Exclusion BioHPLC Columns 1 NEW Size Exclusion Columns 5 m Particle 100Å, 150Å, 300Å, 500Å, 1000Å, 2000Å pore sizes High
More informationFast Agilent HPLC for Large Biomolecules
Fast Agilent HPLC for Large Biomolecules Technical Overview Introduction Agilent media for the analysis of large biomolecules is available in an array of pore sizes to maximize selectivity and capacity
More informationNovel Wide-Pore Superficially Porous Particles for Biomacromolecular Separations
Novel Wide-Pore Superficially Porous Particles for Biomacromolecular Separations S. A. Schuster, B. M. Wagner, B. E. Boyes and J. J. Kirkland Advanced Materials Technology, Inc. 3521 Silverside Rd., Quillen
More informationDEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY KISHORKUMAR L.MULE 1 Department of Chemistry, Shri Jagdish Prasad Jhabarmal Tibrewala
More informationDevelopment and evaluation of Nano-ESI coupled to a triple quadrupole mass spectrometer for quantitative proteomics research
PO-CON138E Development and evaluation of Nano-ESI coupled to a triple quadrupole mass spectrometer for quantitative proteomics research ASMS 213 ThP 115 Shannon L. Cook 1, Hideki Yamamoto 2, Tairo Ogura
More informationFast, Low Pressure Analysis of Food and Beverage Additives Using a Superficially Porous Agilent Poroshell 120 EC-C18 Column
Fast, Low Pressure Analysis of Food and Beverage Additives Using a Superficially Porous Agilent Poroshell 12 EC-C18 Column Application ote Food and Beverage Authors Anne E. Mack and William J. Long Agilent
More informationGradient Elution. Slide 2
Gradient Elution Why choose this separation mode? What HPLC parameters affect a gradient separation? How can I use these parameters to improve my gradient separation? Slide 2 Is Gradient or Isocratic Elution
More informationFlexibility with. Preparative HPLC
Flexibility with Preparative HPLC Date: August 26 th, 2014 Time: 09.00 10.00 am CEST 1 Who are your Presenters? Dr. Christian Textor Product Manager Preparative HPLC Dipl. Biol. Hagen Schlicke Product
More informationDACLATASVIR TABLETS (DACLATASVIRI COMPRESSI) Proposal for The International Pharmacopoeia. (May 2018)
May 2018 Draft for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 DACLATASVIR TABLETS (DACLATASVIRI COMPRESSI) Proposal for The International
More informationNISTmAb characterization with a high-performance RP chromatography column
APPLICATION NOTE 21848 NISTmAb characterization with a high-performance RP chromatography column Author Xin Zhang Thermo Fisher Scientific, Sunnyvale, CA, USA Keywords MAbPac RP column, inter-column reproducibility,
More informationMethod Development of a 2D LC-HRMS Extraction and Detection Method for Organophosphorus Flame Retardants in Environmental Water Samples
Method Development of a 2D LC-HRMS Extraction and Detection Method for Organophosphorus Flame Retardants in Environmental Water Samples Ken Rosnack 1 Lauren Mullin 1,2, Malorie Mella 1, Claude Mallet 1,
More informationCertified Reference Material - Certificate of Analysis
Certified Reference Material - Certificate of Analysis Page 1 of 9 Fluconazole- 13 C 3, Primary Standard Catalog Number: Lot: Retest: July 2015 Description: Fluconazole- 13 C 3 in Methanol Packaging: Solution
More informationEmulation of the Agilent 1100 Series LC Through Waters Empower Software Analysis of an Analgesic Mixture
Agilent 129 Infinity II LC with ISET Emulation of the Agilent 11 Series LC Through Waters Empower Software Analysis of an Analgesic Mixture Application Note Small Molecule Pharmaceuticals Author Melanie
More informationBioHPLC columns. Tim Rice Biocolumn Technical Specialist
BioHPLC columns Tim Rice Biocolumn Technical Specialist AU Typical Application Areas Size Exclusion: Aggregation Analysis Ion Exchange: Charge Isoform Analysis 0.035 Monomer 0.030 0.025 0.020 0.015 Dimer
More informationAgilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility
Agilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility Technical Overview Introduction Agilent AdvanceBio SEC columns are a new family of size exclusion chromatography (SEC) columns
More informationCertified Reference Material - Certificate of Analysis
Certified Reference Material - Certificate of Analysis S(-)-Nicotine, Primary Standard N-008 Page 1 of 7 Catalog Number: N-008 H Lot: Expiration: October 2019 N Description: S(-)-Nicotine in Methanol.
More informationCertified Reference Material - Certificate of Analysis
Certified Reference Material - Certificate of Analysis Cannabigerol (CBG), Primary Standard C-141 Page 1 of 7 Catalog Number: C-141 Lot: Retest: Description: October 2015 Cannabigerol in Methanol Packaging:
More informationUltra High Performance Liquid Chromatograph. Nexera XR C196-E082C
Ultra High Performance Liquid Chromatograph Nexera XR C196-E82C The Most Accessible UHPLC Available Developed with expandability and compatibility in mind, the Nexera XR ultra high performance liquid chromatograph
More information9/2/2014. USP Monograph Modernization. Todays topics. USP basic. Todays topics. - USP basic. - USP publications. - USP monograph modernization
USP Monograph Modernization Procedure Review and Development Donald Min 2 USP basic Since USP's founding in 1820, our operations have grown exponentially: from 11 volunteers collaborating from their respective
More informationOnline UPLC Method for the Support of Cleaning Validation and the Routine Monitoring of Cleaning Procedures
Online UPLC Method for the Support of Cleaning Validation and the Routine Monitoring of Cleaning Procedures Tanya Tollifson Waters Corporation, Milford, MA, USA APPLICATION BENEFITS Online cleaning wash
More information